Measurement of Adherence to Antiretroviral Medications
- 1 December 2002
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 31, S103-S106
- https://doi.org/10.1097/00126334-200212153-00003
Abstract
Measurement of adherence may be important in determining why patients fail antiretroviral therapy. Although patient self-report is by far the most frequently used means of assessing adherence, it overestimates adherence. However, patients who state they are nonadherent almost always are. The pill identification test is a recently described tool that may be useful in clinical practice. The best methods of adherence measurement are pill counts and electronic monitoring. Pill counts suffer from inability to record the time of consumption of therapy. Electronic monitoring enables timing of pill consumption and is the closest to a gold standard for measuring adherence. However, this is only the case if patients are carefully instructed in how to use the device, e.g., not to remove extra doses from their pill bottle. A composite adherence score has been developed that uses electronic monitoring, pill counts, and patient self-report. The authors believe that careful measurement of adherence is essential in the assessment of a patient failing to respond to antiretroviral therapy.Keywords
This publication has 17 references indexed in Scilit:
- Position Paper on Therapeutic Drug Monitoring of Antiretroviral AgentsAIDS Research and Human Retroviruses, 2002
- Value of Patient Self‐Report and Plasma Human Immunodeficiency Virus Protease Inhibitor Level as Markers of Adherence to Antiretroviral Therapy: Relationship to Virologic ResponseClinical Infectious Diseases, 2001
- Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapyInternational Journal of STD & AIDS, 2001
- Improving on a Coin Toss To Predict Patient Adherence to MedicationsAnnals of Internal Medicine, 2001
- Provider Assessment of Adherence to HIV Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Adherence of Human Immunodeficiency Virus–Infected Patients to Antiretroviral TherapyClinical Infectious Diseases, 1999
- Definition and measurement of adherence to antiretroviral drugs in HIV-1-infected patientsThe Lancet, 1999
- The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a markerAIDS, 1998
- Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavirAIDS, 1997